Hgh Humatrope pen lilly 6mg 18iu

80,00 70,00

Humatrope must be kept refrigerated (36° to 46°F [2° to 8°C]) before and after it is mixed. Do not freeze. Once
Humatrope has been mixed and is in liquid form, it must be used within 28 days. Throw away any mixed
Humatrope left over after 28 days

Qty:
Compare

Description

Hgh Humatrope pen lilly 6mg 18iu ; Important Things to Know It is important to learn the names of the parts of the  Humatrope Cartridge  Kit and how these parts work
before injecting yourself or your child. Make sure you have been properly trained by your nurse,
pharmacist or doctor before you mix the drug (add the diluent liquid to the dry Humatrope
powder) or inject it. Wash your hands and be careful to follow the instructions given to you by
your nurse, pharmacist or doctor. After mixing, throw away the diluent syringe in a puncture resistant container such as the type your nurse, pharmacist or doctor has told you to use.
Storage Humatrope must be kept refrigerated (36° to 46°F [2° to 8°C]) before and after it is
mixed. Do not freeze. Once Humatrope has been mixed and is in liquid form, it must be used
within 28 days. Throw away any mixed Humatrope left over after 28 days. Before giving an injection, check the date on the cartridge. Do not use the cartridge if it has expired. WARNING
HUMATROPE CARTRIDGES SHOULD NOT BE USED IF THE PATIENT IS ALLERGIC TO METACRESOL OR

GLYCERIN. Contents
Humatrope contains a growth hormone, a genetic engineering and a structure identical to that
of human origin, secreted in the circulation by a gland in the brain (pituitary gland).
In case of hormonal growth, one tries, by daily subcutaneous injection before bedtime, to
imitate the rate of release of the natural growth hormone.
children
Humatrope is used in the treatment of clinical dwarfism, linked to confirmed growth hormone
deficiency, as well as in the treatment of dwarfism in pregnancy. young girls and women, with
dwarfism and ovarian hypotrophy as main symptoms).
Humatrope is used in the nanism of prepubertal children with chronic renal failure.

Dosage :
Adult:
Give by SC inj once daily; rotate inj sites. Individualize. Weight-based: Initially up to
0.006mg/kg/day; may increase to max 0.0125mg/kg/day. Non-weight based: approx. 0.2mg/day
(range: 0.15 to 0.3mg/day), may increase gradually every 1–2 months by increments of approx.
0.1 to 0.2mg/day.
Children:
Rotate inj sites. Weekly dose should be divided over 6 or 7 days of SC inj. GH deficient: 0.18–
0.3mg/kg/week. Turner syndrome: up to 0.375mg/kg/week. ISS: up to 0.37mg/kg/week. SHOX
deficiency: 0.35mg/kg/week. SGA: up to 0.47mg/kg/week.
Contraindications:
Acute critical illness due to surgical complications or multiple accidental trauma or those with
acute respiratory failure. Closed epiphyses. Active malignancy or growing intracranial tumors.
Diabetic retinopathy. History of upper airway obstruction or sleep apnea, severe obesity, or
severe respiratory impairment in Prader-Willi syndrome (PWS) patients. Not indicated for
treatment of children with growth failure due to confirmed PWS.

Side Effects :

Headache, nausea, vomiting, fatigue, muscle pain, or weakness may occur. If these symptoms
continue or become bothersome, inform your doctor or pharmacist promptly.
Remember that your doctor has prescribed this medication because he or she has judged that
the benefit to you is greater than the risk of side effects. Many people using this medication do
not have serious side effects

Before using any medication, be sure to tell your doctor about any medical conditions or
allergies you may have, medications you are using, and other important things about your
health. Women should mention if they are pregnant or breastfeeding. These factors could
affect how you should use this medicine.
Cancer: For people who have survived cancer in childhood, taking growth hormone can
increase the risk of tumor growth, whether cancerous or not. Talk to your doctor about any
concerns you may have about it.

Diabetes: Somatropin can increase blood sugar levels and change glucose tolerance. People
with diabetes may need to check their blood sugar more often while taking this medication.
If you have diabetes or are predisposed to diabetes, discuss with your doctor how this
medication may affect your medical condition, how your medical condition may affect the
dosing and effectiveness of this medication, and the relevance of specific medical
surveillance.

Hypothyroidism (a low level of thyroid hormones): In cases of rebel hypothyroidism,
treatment with somatropin may be relatively successful. Discuss with your doctor how this
medication may affect your medical condition, how your medical condition may affect the
dosing and effectiveness of this medication, and whether any special monitoring is needed.
Treatment with somatropin may trigger hypothyroidism. If you experience weight gain, muscle
pain or stiffness, constipation, dry skin, or fatigue, it may be due to thyroid hormone deficiency.
You should contact your doctor as soon as possible.

Scoliosis: People with scoliosis are at risks of worsening this condition while using somatropin.
People with scoliosis should discuss with their doctor how this medication may affect their
medical condition, how their medical condition may affect the dosing and effectiveness of this
medication, and whether any medical attention is needed. specific.
Pregnancy: This medication should not be used during pregnancy unless the benefits
outweigh the risks. If pregnancy occurs while you use this medicine, contact your doctor
immediately.

Breast-feeding: It is not known if somatropin passes into breast milk. If you take this medicine
while you are breastfeeding, your baby may feel the effects. Consult your doctor to find out if
you should continue breastfeeding.
Seniors: The safety and effectiveness of this medication have not been established for adults
over 65 years of age.